Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Similar articles for PubMed (Select 23953998)

1.

Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Gulati V, White WB.

J Am Soc Hypertens. 2013 Nov-Dec;7(6):484-93. doi: 10.1016/j.jash.2013.07.003. Epub 2013 Aug 15. Review.

2.

Novel Approaches for the Treatment of the Patient with Resistant Hypertension: Renal Nerve Ablation.

Gulati V, White WB.

Curr Cardiovasc Risk Rep. 2013 Oct;7(5). doi: 10.1007/s12170-013-0334-9.

3.

The pathophysiological basis of renal nerve ablation for the treatment of hypertension.

Ziakas A, Gossios T, Doumas M, Karali K, Megarisiotou A, Stiliadis I.

Curr Vasc Pharmacol. 2014 Jan;12(1):23-9. Review.

PMID:
23905601
4.

Renal sympathetic nerve ablation for treatment-resistant hypertension.

Krum H, Schlaich M, Sobotka P.

Br J Clin Pharmacol. 2013 Oct;76(4):495-503. doi: 10.1111/bcp.12171. Review.

5.

Renal denervation for hypertension: observations and predictions of a founder.

Esler M.

Eur Heart J. 2014 May;35(18):1178-85. doi: 10.1093/eurheartj/ehu091. Epub 2014 Mar 4. Review.

6.

Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.

Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.

Int J Cardiol. 2013 Oct 3;168(3):2214-20. doi: 10.1016/j.ijcard.2013.01.218. Epub 2013 Feb 28.

PMID:
23453868
7.

Renal sympathetic denervation and renal physiology.

Kalaitzidis RG, Karasavvidou D, Siamopoulos KC.

Curr Clin Pharmacol. 2013 Aug;8(3):189-96.

PMID:
23173964
8.

[Renal denervation: current state and future perspectives].

Kara K, Bruck H, Kahlert P, Plicht B, Mahabadi AA, Konorza T, Erbel R.

Herz. 2012 Nov;37(7):746-53. doi: 10.1007/s00059-012-3689-7. German.

PMID:
23073661
9.

[Renal sympathetic denervation. A novel interventional treatment option for therapy-resistant arterial hypertension].

Brandt MC, Mahfoud F, Böhm M, Hoppe UC.

Herz. 2011 Feb;36(1):8-11. doi: 10.1007/s00059-010-3413-4. Review. German.

PMID:
21222093
10.

Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.

Persu A, Renkin J, Asayama K, O'Brien E, Staessen JA.

Expert Rev Cardiovasc Ther. 2013 Jun;11(6):739-49. doi: 10.1586/erc.13.52. Review.

PMID:
23750683
11.

Renal sympathetic denervation using an electroanatomic mapping system.

Miller MA, Gangireddy SR, Dukkipati SR, Koruth JS, d'Avila A, Reddy VY.

J Am Coll Cardiol. 2014 Apr 29;63(16):1697. doi: 10.1016/j.jacc.2013.11.065. Epub 2014 Mar 5. No abstract available.

12.

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.

Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V.

Eur Heart J. 2013 Jul;34(28):2132-40. doi: 10.1093/eurheartj/eht197. Epub 2013 Jun 19.

13.

Renal denervation: a potential new treatment for severe hypertension.

Huan Y, Cohen DL.

Clin Cardiol. 2013 Jan;36(1):10-4. doi: 10.1002/clc.22071. Epub 2012 Nov 2. Review.

PMID:
23124953
14.

Renal denervation for hypertension.

Eleid MF, Schwartz GL, Gulati R.

Curr Probl Cardiol. 2014 Feb;39(2):35-51. doi: 10.1016/j.cpcardiol.2013.11.002. Epub 2013 Nov 11. Review.

PMID:
24412003
15.

International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.

Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsioufis C, Vonend O, Weber MA, Williams B, Zeller T, Esler MD.

J Am Coll Cardiol. 2013 Dec 3;62(22):2031-45. doi: 10.1016/j.jacc.2013.08.1616. Epub 2013 Sep 18.

16.

Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Symplicity HTN-1 Investigators.

Hypertension. 2011 May;57(5):911-7. doi: 10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14.

17.

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M.

Circulation. 2011 May 10;123(18):1940-6. doi: 10.1161/CIRCULATIONAHA.110.991869. Epub 2011 Apr 25.

18.

Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.

Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.

Eur Heart J. 2013 Jul;34(28):2114-21. doi: 10.1093/eurheartj/eht200. Epub 2013 Jun 20.

19.

Renal sympathetic nerve ablation for the management of resistant hypertension: an update.

Thorp AA, Larsen RN, Schlaich MP.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):607-14. doi: 10.1097/MNH.0b013e328365adb1. Review.

PMID:
24100214
20.

Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.

Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.

EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk